Doctor and Pandemic Expert Shares What Investors Need To Know About Coronavirus VaccinesThe Motley Fool • 11/20/20
Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 VaccineBusiness Wire • 11/20/20
A Virologist Explains: mRNA Coronavirus Vaccines And What Investors Should KnowThe Motley Fool • 11/19/20
New Data Shows Higher Efficacy Rate for Pfizer and BioNTech Coronavirus Vaccine CandidateThe Motley Fool • 11/18/20
Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approvalBusiness Insider • 11/18/20
Pfizer-BioNTech Plan Vaccine Emergency Use Filing Within Days After Final Analysis Confirm Efficacy, SafetyBenzinga • 11/18/20
Pfizer's COVID-19 vaccine 95% effective in final results, company to seek approval within daysFox Business • 11/18/20
Pfizer puts COVID vaccine effectiveness at 95%; authorization to be sought soonMarket Watch • 11/18/20
Pfizer-BioNTech Says Covid-19 Vaccine Is 95% Effective, Will Seek Emergency Approval Within DaysForbes • 11/18/20